The Efficacy of Digital Educational Interventions on Parental HPV Knowledge and Attitude, and Their Children's Vaccination Rates
NCT06341738 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 374
Last updated 2024-04-02
Summary
The goal of this clinical trial is to examine in the parental HPV knowledge and attitude, and their children's completion rates in Indonesia. The main question\[s\] it aims to answer are:
* Is the digital educational intervention in improving parent's HPV knowledge in the intervention group compared to the control group?
* Is the digital educational intervention in improving parent's attitude toward HPV vaccine in the intervention group compared to the control group?
* Is the digital educational intervention more effective in increasing children's HPV vaccine completion rates in the intervention group compared to the control group?
Participants in intervention group will:
* watch a 8 minutes video in front of class at once.
* after video education intervention, in 2 weeks, participants received 2 reminder messages before first and second vaccination event, respectively.
Participants in control group will:
• Receive usual announcement regarding vaccine by staff
Conditions
- Health Services Research
Interventions
- BEHAVIORAL
-
Video education about HPV and HPV vaccine
video animation in 8 minutes to promote about HPV and HPV vaccine. the video is played in front of class using LCD projector.
- BEHAVIORAL
-
Electronic reminder messages
Reseachers send reminder messages twice per vaccination event (e.g., 7 days and 1 day before vaccination event), with a total of four times sending reminder messages using the app on the smartphone.
- BEHAVIORAL
-
Usual Information Service
this usual information (e.g., the HPV vaccination event) was delivered face-to-face by staff in front of class
Sponsors & Collaborators
-
Kaohsiung Medical University
lead OTHER
Principal Investigators
-
Yudisa Diaz Lutfi Sandi, PhD · Kaohsiung Medical University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-07-05
- Primary Completion
- 2024-02-01
- Completion
- 2024-02-29
Countries
- Indonesia
Study Locations
More Related Trials
-
Pneumococcal Vaccine Booster Study in Healthy Children 11-18 Months Old Previously Primed With the Same Vaccines
NCT00463437 ·Status: COMPLETED ·Phase: PHASE3
-
Phase I/II, Open Label, Randomized, Safety and Immunogenicity Following DTwP-Hepatitis B-Hib-IPV Vaccine (Bio Farma) in Indonesian Infants
NCT06690515 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Vaccine Social Media Randomized Intervention Trial
NCT01873040 ·Status: COMPLETED ·Phase: NA
-
Booster Vaccination Study With a Pneumococcal Vaccine in Children Primed With the Same Vaccine
NCT00911144 ·Status: COMPLETED ·Phase: PHASE3
-
To Evaluate the Immunogenicity and Safety of DTaP-IPV Vaccine Administered as a Boosting Dose to Healthy Children of 4-6 Years
NCT04618640 ·Status: UNKNOWN ·Phase: PHASE3
-
An RCT Promoting HPV Vaccination Among Chinese MSM
NCT03286907 ·Status: COMPLETED ·Phase: NA
-
Safety of Hib-MenCY-TT Vaccine Versus Licensed Hib Conjugate Vaccine, Given at 2, 4, 6 and 12 to 15 Months of Age
NCT00345579 ·Status: COMPLETED ·Phase: PHASE3
-
DTaP-IPV-HB-PRP-T Combined Vaccine as a Primary Series and a Second Year of Life Booster in HIV-Exposed Infected and Uninfected Infants
NCT02817451 ·Status: COMPLETED ·Phase: PHASE3
-
A Controlled Trial to Assess the Immunogenicity of a Proposed Paediatric Dosing Schedule of Human Papillomavirus Vaccine
NCT00501137 ·Status: COMPLETED ·Phase: PHASE3
-
Safety Study of Measles-Mumps-Rubella-Varicella (MMRV) Vaccine, Priorix-Tetra™ in Children Living in the Philippines
NCT01738841 ·Status: WITHDRAWN
-
Co-administration of Pneumococcal Conjugate Vaccine With DTPa-IPV-Hib Versus Co-administration With DTPa-HBV-IPV/Hib
NCT00652951 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Immunogenicity of a Booster Dose of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744)
NCT01453998 ·Status: COMPLETED ·Phase: PHASE2
-
Immunogenicity and Reactogenicity of a Booster Dose of GSK Bio's DTPa-HBV-IPV/Hib Vaccine
NCT00627458 ·Status: COMPLETED ·Phase: PHASE2
-
The Evaluation of the Prototype Digital Vaccine Platform "TM-VAX" Among User in the Hospital for Tropical Diseases
NCT06843876 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Immuno,Safety of GSK Vaccine 134612 Given at Age of 12-15 Months 15-18 Months Post-priming With GSK Vaccine 792014
NCT00614614 ·Status: COMPLETED ·Phase: PHASE3
-
The Acceptability of the HPV Vaccine Postpartum and With Pediatric Well-child Visits: A Pilot Study
NCT02602626 ·Status: COMPLETED
-
Immunogenicity and Safety of NBP607-QIV Compared to Agrippal in Children Aged 6 to 35 Months
NCT03704740 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Immune Response of Different Pediatric Combination Vaccines.
NCT00255047 ·Status: COMPLETED ·Phase: PHASE3
-
Safety of DTPa-IPV/Hib & DTPa-HBV-IPV/Hib, Followed by DTPa-IPV/Hib Vaccine in Infants Who Received Hepatitis B Vaccine
NCT00325143 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK)'s Infanrix Hexa Vaccine (DTPa-HBV-IPV/Hib) Versus MCM Vaccine BV's Vaxelis Vaccine (DTaP5-HBV-IPV-Hib) in Healthy Infants and Toddlers
NCT04535037 ·Status: COMPLETED ·Phase: PHASE4
-
Study of the Booster Effect of DTaP-IPV-Hep B-PRP~T Combined Vaccine or Infanrix Hexa™ and Prevenar™ in Healthy Infants
NCT01444781 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib Vaccine Followed by the Same Vaccine and Oral Polio Vaccine
NCT01457560 ·Status: COMPLETED ·Phase: PHASE3
-
To Evaluate the Immunogenicity and Safety of Inactivated Hepatitis A Vaccine
NCT03654664 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Immunogenicity of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744)
NCT01248884 ·Status: COMPLETED ·Phase: PHASE2
-
Making Decisions About the Measles-Mumps-Rubella Vaccine
NCT01369394 ·Status: COMPLETED ·Phase: NA